Jesper Bøje Andersen
Professor
Andersen Group
Ole Maaløes Vej 5
2200 København N.
University of Mainz, Medicine 1: Liver lunch
Andersen, Jesper Bøje (Invited speaker)
28 Mar 2017Activity: Talk or presentation types › Lecture and oral contribution
The Italian chapter of the International Cholangiocarcinoma Network (External organisation)
Andersen, Jesper Bøje (Member)
2013Activity: Membership types › Membership in research network
The Hepatobiliary Cancers Foundation (CanLiv): Genomic Basis for Targeted Therapies in Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
The Cancer Genome Atlas: pan-TGFb Network (External organisation)
Andersen, Jesper Bøje (Member)
2017Activity: Membership types › Membership in research network
The Cancer Genome Atlas: Tumor Molecular Pathology (TMP) Analysis Working Group (External organisation)
Andersen, Jesper Bøje (Member)
2017Activity: Membership types › Membership in research network
The Cancer Genome Atlas (TCGA), Cholangiocarcinoma Analysis Working Group (External organisation)
Andersen, Jesper Bøje (Member)
2014 → …Activity: Membership types › Membership in research network
Satorius Research Xchange Forum: Insights, Translation and Solutions
Andersen, Jesper Bøje (Invited speaker)
21 Feb 2017 → 23 Feb 2017Activity: Talk or presentation types › Lecture and oral contribution
Riccardo Cortese memorial lecture
Andersen, Jesper Bøje (Invited speaker)
Jul 2017Activity: Talk or presentation types › Lecture and oral contribution
Nucleic Acids Research (Journal)
Andersen, Jesper Bøje (Review editor)
2006Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy
Andersen, Jesper Bøje (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
Nature Genetics (Journal)
Andersen, Jesper Bøje (Review editor)
2015Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
NAFLD
Andersen, Jesper Bøje (Invited speaker)
24 Nov 2017Activity: Talk or presentation types › Lecture and oral contribution
Mutagen-Brazil: Translational Research
Andersen, Jesper Bøje (Invited speaker)
28 Jan 2016 → 30 Jan 2016Activity: Talk or presentation types › Lecture and oral contribution
Molecular pathogenesis of cholangiocarcinoma
Andersen, Jesper Bøje (Lecturer)
Oct 2015Activity: Talk or presentation types › Lecture and oral contribution
Molecular Classification of Cholangiocarcinoma and Therapeutic Implications
Andersen, Jesper Bøje (Invited speaker)
9 May 2014Activity: Talk or presentation types › Lecture and oral contribution
Liver Cancer Seminar Series
Andersen, Jesper Bøje (Invited speaker)
1 Dec 2016Activity: Talk or presentation types › Lecture and oral contribution
Korean liver week
Andersen, Jesper Bøje (Invited speaker)
Jun 2017Activity: Talk or presentation types › Lecture and oral contribution
Journal of National Cancer Institute (Journal)
Andersen, Jesper Bøje (Review editor)
2007Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
International Liver Cancer Association (ILCA) (External organisation)
Andersen, Jesper Bøje (Member)
2010Activity: Membership types › Membership in research network
International Journal of Rare Diseases & Orphan Drugs (Journal)
Andersen, Jesper Bøje (Member of Editorial Board)
2016 → …Activity: Peer-review and editorial work types › Editor of Research journal › Research
ISICR: The Ribosomal Machinery is a Primary Target of RNase-L Regulation and may mediate its Roles in Senescence and Longevity
Andersen, Jesper Bøje (Speaker)
2007Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2010Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Molecular classification and key drivers of intrahepatic CCA
Andersen, Jesper Bøje (Invited speaker)
Sep 2017Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors
Andersen, Jesper Bøje (Speaker)
2011Activity: Talk or presentation types › Lecture and oral contribution
ID: 93714085
Most downloads
-
726
downloads
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles - correction
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published -
575
downloads
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
198
downloads
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published